药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Arformoterol
Lidoflazine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Lidoflazine.
Arformoterol
Bencyclane
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Bencyclane.
Arformoterol
Gallopamil
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Gallopamil.
Arformoterol
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Tetrahydropalmatine.
Arformoterol
Niguldipine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Niguldipine.
Arformoterol
Lacidipine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Lacidipine.
Arformoterol
Aranidipine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Aranidipine.
Arformoterol
Pinaverium
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Pinaverium.
Arformoterol
Trimebutine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Trimebutine.
Arformoterol
Vilanterol
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Vilanterol.
Arformoterol
Inotersen
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Inotersen.
Arformoterol
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Pipemidic acid.
Arformoterol
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Rufloxacin.
Arformoterol
Piromidic acid
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Piromidic acid.
Arformoterol
Lorajmine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Lorajmine.
Arformoterol
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Oxolinic acid.
Arformoterol
Prajmaline
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Prajmaline.
Arformoterol
Cibenzoline
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Cibenzoline.
Arformoterol
Cicletanine
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Cicletanine.
Arformoterol
Pilsicainide
The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Pilsicainide.